Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
University of Alabama at Birmingham
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
University of Florida
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Columbia University
Sarcoma Alliance for Research through Collaboration
Washington University School of Medicine
OHSU Knight Cancer Institute
Oslo University Hospital
Maria Sklodowska-Curie National Research Institute of Oncology
Sarcoma Alliance for Research through Collaboration
University of Texas Southwestern Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center